Literature DB >> 2378377

Cellular immune responses of patients with uveitis to retinal antigens and their fragments.

M D de Smet1, J H Yamamoto, M Mochizuki, I Gery, V K Singh, T Shinohara, B Wiggert, G J Chader, R B Nussenblatt.   

Abstract

Of two patient populations totaling 82 patients, one in the United States and the other in Japan, we studied the cellular immune responses against S-antigen and interphotoreceptor retinoid binding protein as well as to fragments of each antigen. Behçet's disease, birdshot retinochoroidopathy, pars planitis, ocular sarcoid, sympathetic ophthalmia, and the Vogt-Koyanagi-Harada syndrome were diagnosed in these patients. The response profile of both antigens paralleled each other. This profile was more commonly seen in patients suffering from diseases affecting the retina. Responders reacting to both antigens or to several fragments of an antigen were present. This pattern of response was seen in 26 of the patients tested. Patients with uveitis appeared able to recognize several autoantigens. This might be a consequence of the breakdown of the blood-retinal barrier and may help perpetuate the inflammatory process. Several patients were capable of responding to more than one epitope of the same antigen, which indicates that there are major differences between the experimental model and human autoimmune diseases in the response to autoantigens. Both of these findings may to help develop new immunotherapeutic strategies in the treatment of uveitis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2378377     DOI: 10.1016/s0002-9394(14)76981-8

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  40 in total

Review 1.  Birdshot retinochoroidopathy.

Authors:  A T Gasch; J A Smith; S M Whitcup
Journal:  Br J Ophthalmol       Date:  1999-02       Impact factor: 4.638

Review 2.  Sympathetic ophthalmia: an autoimmune ocular inflammatory disease.

Authors:  C C Chan; M Mochizuki
Journal:  Springer Semin Immunopathol       Date:  1999

Review 3.  Immunomodulation of autoimmune responses with monoclonal antibodies and immunoadhesins: treatment of ocular inflammatory disease in the next millennium.

Authors:  A D Dick; J D Isaacs
Journal:  Br J Ophthalmol       Date:  1999-11       Impact factor: 4.638

Review 4.  Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51.

Authors:  H Direskeneli
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

5.  Outcomes of birdshot chorioretinopathy treated with an intravitreal sustained-release fluocinolone acetonide-containing device.

Authors:  Ryan B Rush; Debra A Goldstein; David G Callanan; Beeran Meghpara; William J Feuer; Janet L Davis
Journal:  Am J Ophthalmol       Date:  2011-02-01       Impact factor: 5.258

6.  Autoantigens signal through chemokine receptors: uveitis antigens induce CXCR3- and CXCR5-expressing lymphocytes and immature dendritic cells to migrate.

Authors:  O M Zack Howard; Hui Fang Dong; Shao Bo Su; Rachel R Caspi; Xin Chen; Paul Plotz; Joost J Oppenheim
Journal:  Blood       Date:  2005-02-15       Impact factor: 22.113

7.  Cellular immune responses to retinal antigens in retinitis pigmentosa.

Authors:  J H Yamamoto; O Okajima; M Mochizuki; T Shinohara; B Wiggert; G J Chader; I Gery; R B Nussenblatt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

8.  Definition of the HLA-A29 peptide ligand motif allows prediction of potential T-cell epitopes from the retinal soluble antigen, a candidate autoantigen in birdshot retinopathy.

Authors:  F Boisgerault; I Khalil; V Tieng; F Connan; T Tabary; J H Cohen; J Choppin; D Charron; A Toubert
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

Review 9.  The role of infections in autoimmune disease.

Authors:  A M Ercolini; S D Miller
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

10.  Cellular autoimmunity to retinal specific antigens in patients with Behçet's disease.

Authors:  J H Yamamoto; M Minami; G Inaba; K Masuda; M Mochizuki
Journal:  Br J Ophthalmol       Date:  1993-09       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.